{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Tibbitts DC"],"funding":["National Institute of Arthritis and Musculoskeletal and Skin Diseases","National Institutes of Health National Cancer Institute","NICHD NIH HHS","NCI NIH HHS","National Institutes of Health","NIAMS NIH HHS","National Institute of Child Health and Human Development"],"pagination":["102180"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11890949"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["16(2)"],"pubmed_abstract":["<h4>Introduction</h4>Androgen deprivation therapy (ADT) increases the risk of frailty, falls, and poor physical functioning in older adults with prostate cancer. Detection of frailty is limited to self-report instruments and performance measures, so unbiased tools are needed. We investigated relationships between an unbiased measure - daily life mobility - and ADT history, frailty, fall history, and functioning in older prostate cancer survivors treated with ADT.<h4>Materials and methods</h4>This cross-sectional study recruited prostate cancer survivors with a history of ADT from an exercise clinical trial, an academic medical center, and the community. Participants completed performance measures and surveys to assess frailty, fall history, and physical functioning, then wore instrumented "],"journal":["Journal of geriatric oncology"],"pubmed_title":["Daily life mobility detects frailty, falls, and functioning in older prostate cancer survivors treated with androgen deprivation therapy."],"pmcid":["PMC11890949"],"funding_grant_id":["R01HD100383-01","K12 AR084221","R01CA222605","R01 CA222605","K12AR084221","R01 HD100383"],"pubmed_authors":["Graff JN","Stoyles S","Dieckmann NF","Winters-Stone KM","Tibbitts DC","Mancini M","El-Gohary M","Horak FB"],"additional_accession":[]},"is_claimable":false,"name":"Daily life mobility detects frailty, falls, and functioning in older prostate cancer survivors treated with androgen deprivation therapy.","description":"<h4>Introduction</h4>Androgen deprivation therapy (ADT) increases the risk of frailty, falls, and poor physical functioning in older adults with prostate cancer. Detection of frailty is limited to self-report instruments and performance measures, so unbiased tools are needed. We investigated relationships between an unbiased measure - daily life mobility - and ADT history, frailty, fall history, and functioning in older prostate cancer survivors treated with ADT.<h4>Materials and methods</h4>This cross-sectional study recruited prostate cancer survivors with a history of ADT from an exercise clinical trial, an academic medical center, and the community. Participants completed performance measures and surveys to assess frailty, fall history, and physical functioning, then wore instrumented ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Mar","modification":"2026-07-16T23:10:27.275Z","creation":"2026-07-12T03:10:42.231Z"},"accession":"S-EPMC11890949","cross_references":{"pubmed":["39708402"],"doi":["10.1016/j.jgo.2024.102180"]}}